US$ 26.54
retatrutide study results Results: 28.3% Weight Loss Data Retatrutide Research Peptide | GLP3-R
Description
Here's what that looks like, in their own words

Behavioral therapy: CBT, motivational interviewing, structured weight-loss programs

FDA-Approved : It is FDA-approved for type 2 diabetes, chronic weight management and obstructive sleep apnea (OSA), ensuring safety and efficacy for its intended use

The logic behind this approach is that the concomitant activation of GLP1 and estrogen receptors may drive additional favorable effects, when compared with the individual activation of these pathways, which are known to conduct, on their own, beneficial metabolic actions on energy and glucose homeostasis 52

This causes greasy skin because it increases production of sebum, the oily substance secreted at the base of hairs to protect and lubricate the skin 2
Front Endocrinol (2019) 10:294
